Register for email alerts and news feeds:
This journal | BMJ Group
rss
Drug and Therapeutics Bulletin 2006;44:49-53; doi:10.1136/dtb.2006.44749
Copyright © 2006 by the BMJ Publishing Group Ltd.

Managing Bell's palsy

Each year in the UK, around 1 in 5,000 people develop Bell's palsy – a unilateral lower motor neurone facial weakness of rapid onset that can be physically and psychologically disabling.1 While around 71% of patients recover normal function of the facial muscles without treatment, 13% are left with slight weakness and 16% with moderate to severe weakness resulting in major facial dysfunction.2,3 People who recover usually do so quickly, with 85% of them reporting some improvement in the first 3 weeks.2 There is longstanding controversy about what, if any, treatment should be initiated for Bell's palsy. Here we discuss the management of patients with this condition.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles: